Yagishita S, Inoue M
Department of Pathology, Kanagawa Rehabilitation Center, Japan.
Pathol Int. 1997 Jan;47(1):1-15. doi: 10.1111/j.1440-1827.1997.tb04429.x.
The recent advances in gene analysis have greatly facilitated the classification of autosomal dominant spinocerebellar ataxia (SCA). Analyses of linkage in large families with SCA have assigned gene foci to at least 8 chromosomes. One gene is located in the short arm of chromosome 6 (6p22-p23) and causes spinocerebellar ataxia type 1 (SCA1). A gene in the long arm of chromosome 14 (14q24.3-q32) underlies Machado-Joseph disease (MJD). A third gene locus is assigned to the short arm of chromosome 12 (12p2-pter) causing dentatorubropallidoluysian atrophy (DRPLA). The gene for spinocerebellar ataxia type 2 (SCA2) is located in the 12q23-24. Subsequently, a sporadic counterpart of hereditary olivopontocerebellar atrophy of the Menzel type is clearly defined, and all the syndromes (non-hereditary olivopontocerebellar atrophy, striatonigral degeneration and Shy-Drager syndrome) are now lumped under the term of multiple system atrophy (MSA). Oligodendroglial cytoplasmic inclusions appear to be specific for and diagnostic of MSA. As the clinical features in SCA are variable and often appear to overlap with one another, which makes accurate classification difficult if not possible, the genotype is required for their unequivocal classification. However, major neuropathological features clearly distinguish SCA1 from SCA3/ MJD cases; the medial segment of the globus pallidus and intermediolateral column lesions in SCA3/MJD, and inferior olive and cerebellar cortical degeneration in SCA1. It has been stated that neurodegeneration in SCA3/MJD is more homogeneous than in SCA1 or SCA2 and that degeneration of the pallidoluysian system is not present in the latter. The pertinent pathology in each of the three types of SCA is illustrated. The background of clinicopathology and genetic analysis of dentatorubropallidoluysian atrophy is also reviewed.
基因分析的最新进展极大地推动了常染色体显性遗传性脊髓小脑共济失调(SCA)的分类。对患有SCA的大家族进行连锁分析已将基因位点定位到至少8条染色体上。一个基因位于6号染色体短臂(6p22 - p23),导致脊髓小脑共济失调1型(SCA1)。位于14号染色体长臂(14q24.3 - q32)的一个基因是马查多 - 约瑟夫病(MJD)的基础。第三个基因位点定位于12号染色体短臂(12p2 - pter),导致齿状核红核苍白球路易体萎缩(DRPLA)。脊髓小脑共济失调2型(SCA2)的基因位于12q23 - 24。随后,明确界定了门泽尔型遗传性橄榄桥脑小脑萎缩的散发性对应类型,并且所有综合征(非遗传性橄榄桥脑小脑萎缩、纹状体黑质变性和夏伊 - 德雷格综合征)现在都被归为多系统萎缩(MSA)这一术语之下。少突胶质细胞胞质内包涵体似乎是MSA的特异性标志且具有诊断意义。由于SCA的临床特征多变且常常相互重叠,这使得准确分类即便不是不可能也很困难,因此需要基因型来进行明确分类。然而,主要的神经病理学特征清楚地将SCA1与SCA3/MJD病例区分开来;SCA3/MJD中苍白球内侧段和中间外侧柱病变,以及SCA1中橄榄下核和小脑皮质变性。有人指出,SCA3/MJD中的神经变性比SCA1或SCA2中的更均匀,并且后两者不存在苍白球路易体系统的变性。文中展示了三种类型SCA各自相关的病理学表现。还综述了齿状核红核苍白球路易体萎缩的临床病理学和基因分析背景。